TP53 and ovarian carcinoma: We hypothesize that Chr3(q26.2) Amp flags hypoxic ovarian cancer tumors with genomic instability, p62 accumulation from TP53 mutation-induced autophagy deficiency, and suppressed HRR pathway, leading to persistent DNA damage and cell cycle arrest (Fig. S7G).